Detailed information for compound 1643395

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 400.599 | Formula: C28H36N2
  • H donors: 0 H acceptors: 0 LogP: 7.03 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN1CCN(CC1)c1ccc(cc1)C(C12CC3CC(C2)CC(C1)C3)c1ccccc1
  • InChi: 1S/C28H36N2/c1-29-11-13-30(14-12-29)26-9-7-25(8-10-26)27(24-5-3-2-4-6-24)28-18-21-15-22(19-28)17-23(16-21)20-28/h2-10,21-23,27H,11-20H2,1H3
  • InChiKey: ZLOIGSNUNDZINZ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens sigma non-opioid intracellular receptor 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Candida albicans sterol C8-C7 isomerase Get druggable targets OG5_131051 All targets in OG5_131051
Trypanosoma congolense C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Leishmania braziliensis C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_131051 All targets in OG5_131051
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_131051 All targets in OG5_131051
Leishmania major C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051
Trypanosoma congolense C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Trypanosoma brucei gambiense C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Leishmania mexicana C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051
Leishmania infantum C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051
Brugia malayi ERG2 and Sigma1 receptor like protein Get druggable targets OG5_131051 All targets in OG5_131051
Trypanosoma brucei C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Candida albicans sterol C8-C7 isomerase Get druggable targets OG5_131051 All targets in OG5_131051
Trypanosoma cruzi C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Leishmania donovani C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0104 0.07 0.07
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0802 1 1
Echinococcus granulosus geminin 0.0379 0.4365 0.4365
Onchocerca volvulus 0.0285 0.3113 0.3113
Loa Loa (eye worm) SWIB/MDM2 domain-containing protein 0.0802 1 1
Brugia malayi SWIB/MDM2 domain containing protein 0.0802 1 1
Loa Loa (eye worm) hypothetical protein 0.0285 0.3113 0.3113
Plasmodium vivax SWIB/MDM2 domain-containing protein, putative 0.0802 1 0.5
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0802 1 1
Schistosoma mansoni zinc finger protein 0.0285 0.3113 0.3113
Toxoplasma gondii DNA topoisomerase domain-containing protein 0.0802 1 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0104 0.07 0.07
Schistosoma mansoni brg-1 associated factor 0.0802 1 1
Chlamydia trachomatis SWIB complex protein 0.0802 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0285 0.3113 0.3113
Trichomonas vaginalis conserved hypothetical protein 0.0802 1 0.5
Brugia malayi ERG2 and Sigma1 receptor like protein 0.064 0.7843 0.7843
Loa Loa (eye worm) hypothetical protein 0.0327 0.3671 0.3671
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0104 0.07 0.07
Echinococcus multilocularis Zinc finger, RanBP2 type 0.0285 0.3113 0.3113
Loa Loa (eye worm) hypothetical protein 0.0285 0.3113 0.3113
Echinococcus multilocularis geminin 0.0379 0.4365 0.4365
Schistosoma mansoni fusion 0.0285 0.3113 0.3113
Echinococcus multilocularis zinc finger protein Ran binding 0.0285 0.3113 0.3113
Onchocerca volvulus 0.0285 0.3113 0.3113
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0104 0.07 0.07
Echinococcus multilocularis Nuclear pore complex protein Nup153 0.0285 0.3113 0.3113
Schistosoma mansoni hypothetical protein 0.0379 0.4365 0.4365
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0104 0.07 0.07
Loa Loa (eye worm) hypothetical protein 0.0285 0.3113 0.3113
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.0285 0.3113 0.3113
Schistosoma mansoni hypothetical protein 0.0285 0.3113 0.3113
Brugia malayi brahma associated protein 60 kDa 0.0802 1 1
Echinococcus multilocularis SWI:SNF matrix associated 0.0802 1 1
Echinococcus multilocularis Upstream activation factor subunit UAF30 0.0802 1 1
Toxoplasma gondii SWIB/MDM2 domain-containing protein 0.0802 1 1
Schistosoma mansoni hypothetical protein 0.0802 1 1
Onchocerca volvulus 0.0802 1 1
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0104 0.07 0.07
Echinococcus granulosus zinc finger protein Ran binding 0.0285 0.3113 0.3113
Onchocerca volvulus Ubiquitin thioesterase ZRANB1 homolog 0.0285 0.3113 0.3113
Echinococcus multilocularis ring and YY1 binding protein 0.0285 0.3113 0.3113
Loa Loa (eye worm) hypothetical protein 0.064 0.7843 0.7843
Brugia malayi YY1-associated factor 2 0.0285 0.3113 0.3113
Leishmania major C-8 sterol isomerase-like protein 0.064 0.7843 1
Echinococcus granulosus Zinc finger RanBP2 type 0.0285 0.3113 0.3113
Echinococcus granulosus Upstream activation factor subunit UAF30 0.0802 1 1
Onchocerca volvulus 0.0285 0.3113 0.3113
Echinococcus multilocularis SWI:SNF matrix associated 0.0802 1 1
Echinococcus granulosus Nuclear pore complex protein Nup153 0.0285 0.3113 0.3113
Schistosoma mansoni TRABID protein (C64 family) 0.0285 0.3113 0.3113
Schistosoma mansoni hypothetical protein 0.0802 1 1
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.0285 0.3113 0.3113
Loa Loa (eye worm) hypothetical protein 0.0285 0.3113 0.3113
Schistosoma mansoni RNA binding protein 0.0285 0.3113 0.3113
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0104 0.07 0.07
Plasmodium vivax hypothetical protein, conserved 0.0802 1 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.0802 1 1
Schistosoma mansoni hypothetical protein 0.0802 1 1
Echinococcus granulosus ring and YY1 binding protein 0.0285 0.3113 0.3113
Onchocerca volvulus 0.0285 0.3113 0.3113
Trypanosoma cruzi C-8 sterol isomerase, putative 0.064 0.7843 1
Echinococcus granulosus SWI:SNF matrix associated 0.0802 1 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0104 0.07 0.07
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.0285 0.3113 0.3113
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.0285 0.3113 0.3113
Chlamydia trachomatis DNA topoisomerase I 0.0802 1 0.5
Loa Loa (eye worm) brahma associated protein 0.0802 1 1
Trypanosoma brucei C-8 sterol isomerase, putative 0.064 0.7843 1
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0104 0.07 0.07
Schistosoma mansoni hypothetical protein 0.0379 0.4365 0.4365

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) Analgesic activity against formalin-induced neuropathic pain in paclitaxel treated CD1 mouse assessed as decrease of time spent in paw licking at 100 mg/kg, po administered 14 days post paclitaxel dosing and 1 hr prior formalin challenge measured for 0 to 5 mins post formalin challenge ChEMBL. 22512908
Activity (ADMET) Toxicity in CD1 mouse assessed as weight loss at 40 mg/kg, ip after 3 to 4 weeks chronic treatment ChEMBL. 22512908
Activity (functional) Analgesic activity against formalin-induced neuropathic pain in paclitaxel treated CD1 mouse assessed as decrease of time spent in paw licking at 100 mg/kg, po administered 14 days post paclitaxel dosing and 1 hr prior formalin challenge measured for 35 to 40 mins post formalin challenge ChEMBL. 22512908
Activity (ADMET) Toxicity in SCID mouse assessed as weight loss at 40 mg/kg, ip after 3 to 4 weeks chronic treatment ChEMBL. 22512908
Activity (ADMET) Toxicity in SCID mouse assessed as mortality at 40 mg/kg, ip after 3 to 4 weeks chronic treatment ChEMBL. 22512908
Activity (ADMET) Toxicity in CD1 mouse assessed as mortality at 40 mg/kg, ip after 3 to 4 weeks chronic treatment ChEMBL. 22512908
GI50 (functional) = 4.92 uM Growth inhibition of human HCT116 cells after 48 hrs by SRB assay ChEMBL. 22512908
IC50 (binding) = 3.2 nM Displacement of [3H](+)pentazocine from sigma-1 receptor expressed in human Jurkat cell membranes after 2 hrs by liquid scintillation spectroscopy ChEMBL. 22512908

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.